Matches in Wikidata for { <http://www.wikidata.org/entity/Q39144634> ?p ?o ?g. }
- Q39144634 description "2016 nî lūn-bûn" @default.
- Q39144634 description "2016年の論文" @default.
- Q39144634 description "2016年論文" @default.
- Q39144634 description "2016年論文" @default.
- Q39144634 description "2016年論文" @default.
- Q39144634 description "2016年論文" @default.
- Q39144634 description "2016年論文" @default.
- Q39144634 description "2016年论文" @default.
- Q39144634 description "2016年论文" @default.
- Q39144634 description "2016年论文" @default.
- Q39144634 description "2016年论文" @default.
- Q39144634 description "2016年论文" @default.
- Q39144634 description "2016年论文" @default.
- Q39144634 description "2016년 논문" @default.
- Q39144634 description "article científic" @default.
- Q39144634 description "article scientific" @default.
- Q39144634 description "article scientifique" @default.
- Q39144634 description "articol științific" @default.
- Q39144634 description "articolo scientifico" @default.
- Q39144634 description "artigo científico" @default.
- Q39144634 description "artigo científico" @default.
- Q39144634 description "artigo científico" @default.
- Q39144634 description "artikel ilmiah" @default.
- Q39144634 description "artikull shkencor" @default.
- Q39144634 description "artikulong pang-agham" @default.
- Q39144634 description "artykuł naukowy" @default.
- Q39144634 description "artículo científico publicado en 2016" @default.
- Q39144634 description "artículu científicu espublizáu en 2016" @default.
- Q39144634 description "bilimsel makale" @default.
- Q39144634 description "bài báo khoa học" @default.
- Q39144634 description "naučni članak" @default.
- Q39144634 description "scienca artikolo" @default.
- Q39144634 description "scientific article published on 29 November 2016" @default.
- Q39144634 description "scientific article published on 29 November 2016" @default.
- Q39144634 description "scientific article published on 29 November 2016" @default.
- Q39144634 description "teaduslik artikkel" @default.
- Q39144634 description "tieteellinen artikkeli" @default.
- Q39144634 description "tudományos cikk" @default.
- Q39144634 description "vedecký článok" @default.
- Q39144634 description "vetenskaplig artikel" @default.
- Q39144634 description "videnskabelig artikel" @default.
- Q39144634 description "vitenskapelig artikkel" @default.
- Q39144634 description "vitskapeleg artikkel" @default.
- Q39144634 description "vědecký článek" @default.
- Q39144634 description "wetenschappelijk artikel" @default.
- Q39144634 description "wissenschaftlicher Artikel" @default.
- Q39144634 description "επιστημονικό άρθρο" @default.
- Q39144634 description "мақолаи илмӣ" @default.
- Q39144634 description "наукова стаття, опублікована в листопаді 2016" @default.
- Q39144634 description "научна статия" @default.
- Q39144634 description "научная статья" @default.
- Q39144634 description "научни чланак" @default.
- Q39144634 description "научни чланак" @default.
- Q39144634 description "מאמר מדעי" @default.
- Q39144634 description "مقالة علمية نشرت في 29 نوفمبر 2016" @default.
- Q39144634 description "২৯ নভেম্বর ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q39144634 description "บทความทางวิทยาศาสตร์" @default.
- Q39144634 description "სამეცნიერო სტატია" @default.
- Q39144634 name "The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes" @default.
- Q39144634 name "The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes" @default.
- Q39144634 name "The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes" @default.
- Q39144634 type Item @default.
- Q39144634 label "The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes" @default.
- Q39144634 label "The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes" @default.
- Q39144634 label "The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes" @default.
- Q39144634 prefLabel "The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes" @default.
- Q39144634 prefLabel "The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes" @default.
- Q39144634 prefLabel "The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes" @default.
- Q39144634 P1433 Q39144634-0DBF883D-2C8C-4478-BD37-0E025950684E @default.
- Q39144634 P1476 Q39144634-D17BE1C8-88F9-4AFE-ADBD-09381A3CA119 @default.
- Q39144634 P2093 Q39144634-26B30CA2-7136-43E0-AF81-A2E0B76C9B9D @default.
- Q39144634 P2093 Q39144634-885DBD2A-C12B-4F4F-A085-165638C466B9 @default.
- Q39144634 P2093 Q39144634-957404F2-E5A7-47FA-8F29-CE94C82C8EBF @default.
- Q39144634 P2093 Q39144634-AD3561D2-EE3E-4549-841F-35D585038D8F @default.
- Q39144634 P2093 Q39144634-B4CF6478-B962-49C7-9658-BC2F286BBDFF @default.
- Q39144634 P304 Q39144634-6E43C486-9A0A-4534-A5EC-A2FD4ECE54BD @default.
- Q39144634 P31 Q39144634-CF9691ED-DF6A-4F4F-9A54-81DF2ED1D186 @default.
- Q39144634 P356 Q39144634-CFA498A8-2204-4BD9-9DCB-30A175C95B2D @default.
- Q39144634 P407 Q39144634-F3885D1C-CF74-43DD-A5D9-378D2641B1E6 @default.
- Q39144634 P433 Q39144634-E0026204-5286-4983-A669-7501CA838AC0 @default.
- Q39144634 P478 Q39144634-B1BEFE97-EF85-4D7A-B6FF-A81F1DEF0582 @default.
- Q39144634 P50 Q39144634-079983E1-DDEB-4BDA-9695-85D3B19DD613 @default.
- Q39144634 P577 Q39144634-187460DA-31CC-4C6A-9890-D40D1DA3F925 @default.
- Q39144634 P698 Q39144634-2AFD5CAF-D0DF-4C81-93B9-575D1B6C49FE @default.
- Q39144634 P921 Q39144634-4A3BECB5-8DA1-4203-8C2E-9D355D4BDDDB @default.
- Q39144634 P921 Q39144634-613CD3DB-5EEB-4B09-A8D4-A65D849B17E2 @default.
- Q39144634 P921 Q39144634-c15f7bec-deed-48c9-bd4d-c9d6f1d9a814 @default.
- Q39144634 P356 DC16-1353 @default.
- Q39144634 P698 27899497 @default.
- Q39144634 P1433 Q5270111 @default.
- Q39144634 P1476 "The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes" @default.
- Q39144634 P2093 "Anjun Cao" @default.
- Q39144634 P2093 "April Slee" @default.
- Q39144634 P2093 "Helena W Rodbard" @default.
- Q39144634 P2093 "Maria Alba" @default.
- Q39144634 P2093 "Shana B Traina" @default.
- Q39144634 P304 "171-180" @default.
- Q39144634 P31 Q13442814 @default.
- Q39144634 P356 "10.2337/DC16-1353" @default.
- Q39144634 P407 Q1860 @default.